PD
Pankaj Dwivedi
Proteovant Therapeutics, Genentech Inc, University of Cincinnati, California State University System, AbbVie Inc, University of Allahabad
About
Proteomics, Protein Biochemistry, Cancer Biology, Hematology & Leukemia, Targeted Protein Degradation ( PROTAC & Molecular Glue), Proteomics Data Analysis, R programming
Employment
-
Proteovant Therapeutics Assistant Director2022 - Present
-
Genentech Inc Principal Scientific Researcher2020 - 2022
-
AbbVie Inc Post-doc fellow2018 - 2020
-
Proctor & Gamble (P&G) PhD intern (Hair Biology)2017 - 2017
-
University of Cincinnati Medical Center Graduate Research Assistant2012 - 2018
-
Califronia State University Graduate Assistant/Teaching Associate2009 - 2012
Education
-
University of Cincinnati PhD2012 - 2018
-
California State University System MS2009 - 2012
-
University of Allahabad MSc2004 - 2006
Projects & Funding
Projects & funding information is unavailable.
Publications (13)
- OTUD6 deubiquitination of RPS7/eS7 on the free 40 S ribosome regulates global protein translation and stress Save
- Editorial: Attention to finer-details: Progression from bulk to single-cell studies Save
- Antibody targeting of E3 ubiquitin ligases for receptor degradation. Save
- Understanding the effect of carrier proteomes in single cell proteomic studies - key lessons Save
- ROS mediated apoptotic pathways in primary effusion lymphoma: Comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma Save
- Mouse models of neutropenia reveal progenitor-stage-specific defects Save
- SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling. Save
- Phospho serine and threonine analysis of normal and mutated granulocyte colony stimulating factor receptors Save
- Time resolved quantitative phospho-tyrosine analysis reveals Bruton’s Tyrosine kinase mediated signaling downstream of the mutated granulocyte-colony stimulating factor receptors Save
- Phosphoproteomics analysis of normal and malignant granulocyte-colony stimulating factor receptor signaling Save